Valion Bio (VBIO) Receivables (2021 - 2025)
Valion Bio (VBIO) posted Receivables of $19,000 for Q3 2025, up 111.1% from $9,000 a year earlier and up 46.2% from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Receivables (2021 - 2025) Analysis & Trends
At the end of FY2024, Valion Bio's Receivables came in at $69,000, down 60.3% from FY2023.
- Annual Receivables shows a three-year compound annual growth rate of -9.1% (FY2021 to FY2024).
- In prior years, Valion Bio's Receivables was $174,000 in FY2023 (+62.6%), $107,000 in FY2022 (+16.3%) and $92,000 in FY2021.
- Quarterly Receivables has run from a low of $9,000 in Q3 2024 to a high of $174,000 in Q4 2023 over five years.
- On a year-over-year basis, Receivables increased in four of the last eight quarters, with an average decline of 3.5%.
- The strongest year-over-year quarter for Receivables in the past five years was Q3 2025, with growth of 111.1%; the weakest was Q3 2024, with a decline of 93.1%.
- According to Business Quant data, Receivables for the three prior quarters was $13,000 (Q2 2025), $13,000 (Q1 2025) and $69,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Valion Bio | 129,792.00 | -19.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 174,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 117,000.00 |
| Dec 31, 2021 | 92,000.00 |
API Access
Valion Bio Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();